MANIPAL HEALTH ENTERPRI L vs Sun Pharmaceutical Industries Ltd
A side-by-side comparison of MANIPAL HEALTH ENTERPRI L (MANIPALHOS) and Sun Pharmaceutical Industries Ltd (MIL) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.
On the numbers, MANIPAL HEALTH ENTERPRI L leads MANIPALHOS vs MIL on 8 of 14 metrics (1 undecided). See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).
- Valuation13
- Profitability40
- Growth10
- Size & financial health22
Each axis shows this group's split of that metric, scaled so the leader sits at the edge. Relative to each other, not an absolute score.
Valuation
MIL takes 3/4How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.
Profitability
MANIPALHOS takes 4/4How efficiently each company turns capital and sales into profit. Higher is better.
Growth
MANIPALHOS takes 1/2Three-year compounded growth. Faster-growing businesses can justify a higher valuation.
Size & financial health
EvenScale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.
- + ["Company has delivered good profit growth of 26.0% CAGR over last 5 years"]
- − ["Company has a low return on equity of 10.2% over last 3 years."]
- + ["Company is almost debt free.", "Company has been maintaining a healthy dividend payout of 34.1%"]
- − ["The company has delivered a poor sales growth of 11.8% over past five years."]
This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.